Breaking News2 years ago
Biogen wins accelerated FDA approval for treatment for rare form of ALS
[ad_1] The U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic...
